SEINE BIO · Research, evidence & your next steps
Where mitochondrial science meets movement.
MOTS-c is part of a compelling research story connecting cellular stress, metabolism and exercise. Explore the biology behind the interest and bring your questions about performance and metabolic health to a clinician.
This catalog formulation is investigational, not an FDA approved treatment.
How MOTS-C works
MOTS-c is a mitochondria-derived peptide studied in metabolic stress and exercise adaptation. Changes in the body’s own MOTS-c after exercise do not prove that injecting a synthetic product reproduces those benefits.
Why it’s getting attention
A primary study linked exercise with endogenous MOTS-c in humans and reported performance effects of administered peptide in mice. The animal treatment results do not establish improved human fitness, insulin sensitivity or longevity from this catalog product.
Protocol reference at a glance
Reference context, not your prescription. No established patient protocol was identified for this formulation. The chart summarizes research context, not directions for use.
| Stage | What to expect from the evidence |
|---|---|
| Research setting | No validated routine human injection schedule established by the cited study. |
| Starting / loading phase | No validated routine-care starting or loading dose established for this exact formulation. |
| Standard dose / maximum | No validated standard patient dose or safe maximum established here. |
| Maintenance / cycles | No validated ongoing maintenance or cycling protocol identified. |
Presentation & administration
Animal administration routes and human blood measurements cannot establish a subcutaneous, nasal or device-specific patient protocol.
Catalog presentation: Vial / Cartridge / Disposable Injection Pen. Listed strength options: 10 mg; 20 mg; 40 mg. One catalog unit is one selected presentation—not a box containing every pictured format. Total container content is not a personal dose, and an illustration does not verify an approved route or device.
Risks & common side effects
- Human adverse-effect rates, interactions and long-term outcomes for this exact formulation are not established.
- Potential metabolic effects require caution around diabetes treatment and other experimental agents. Product identity, immune reactions and injection complications also need review.
Tell your clinician about new or persistent symptoms and other medicines. Changes to treatment should be clinician-directed.
Other options worth discussing
Regular physical activity, resistance training and management of cardiovascular or metabolic risk have more established roles. Investigate persistent fatigue or reduced exercise tolerance clinically. “More established” does not mean risk-free or suitable for everyone; a clinician should compare benefits, contraindications and your preferences.
When to seek help
Unexpected symptoms or suspected infection require assessment; severe allergic symptoms, fainting or confusion need urgent care.
Finished-product quality, concentration and route require verification. Review allergies, pregnancy, health conditions and other medicines with your clinician.
Do not wait for a portal reply in an emergency. Call 911 or seek emergency care for severe or rapidly worsening symptoms.
A few useful answers
Can it replace exercise?
No. The study does not establish a safe or effective replacement for physical activity.
Does an exercise-related blood level prove injections work?
No. Measuring an endogenous peptide is different from testing a treatment.
Does clinician authorization guarantee access?
No. Clinical appropriateness, lawful availability and a verified finished formulation must each be established. An Rx setting, luxury image or research-series label does not create regulatory approval.
Research & references
General information, not a prescription or a guarantee of results. Research and reference-label schedules do not replace instructions for your exact prescribed product. Clinical suitability and lawful availability require separate confirmation.
Make your next step an informed one.
Share what you want to improve, what you have already tried, and the questions you have about MOTS-C. Your care team can help put the evidence and alternatives in context.
Sign-in may be required. This is not an emergency service or a guarantee that this product is available.
Product codes & historical records
Historical catalog reference
Source snapshot captured October 11, 2026. Historical catalog reference only; this draft is unavailable for purchase. Supplier prices, packaging, stock and reported test content describe the archived source entries, not a current SEINE BIO supply lot.
MOTS-C — 10 mg per vial
Product Code: 2310
Original supplier title: 2310(10*10mg)
| Supplier | Supplier |
|---|---|
| Supplier pack | 10 vials |
| Nominal content | 10 mg per vial |
| Source listed price (USD) | $70.00 per supplier pack |
| Source regular price (USD) | $90.00 per supplier pack |
| Source price per unit (USD) | $7.00 (arithmetic reference) |
| Batch shown on product page | 2026082310 |
| Source stock snapshot | 85 in stock — US warehouse |
| Source weight | Not displayed |
| Source dimensions | Not displayed |
Archived supplier description: No separate product description was displayed.